CBP22, a Novel Bacteriocin Isolated from <i>Clostridium butyricum</i> ZJU-F1, Protects against LPS-Induced Intestinal Injury through Maintaining the Tight Junction Complex

<div>Experimental design and scheme of animal treatments.</div>

Mediators of Inflammation

fig1

Figure 1

Figure 1: CBP22, a Novel Bacteriocin Isolated from <i>Clostridium butyricum</i> ZJU-F1, Protects against LPS-Induced Intestinal Injury through Maintaining the Tight Junction Complex 

Figure 1 | CBP22, a Novel Bacteriocin Isolated from Clostridium butyricum ZJU-F1, Protects against LPS-Induced Intestinal Injury through Maintaining the Tight Junction Complex 